#858of 1,000 in 2025

HHT Foundation

Location
Monkton, Maryland
Sector
Community improvement
Founded
1990
243%Three-year growth, FY2022 to FY2025
$8.0MFY2025 revenue
19Employees, FY2025
#50of 56 in Community improvement
#17of 20 in Maryland

Revenue by fiscal year

FY2022: $2,335,998 $2.3M FY22 FY2023: $3,419,951 $3.4M FY23 FY2024: $5,328,059 $5.3M FY24 FY2025: $8,007,558 $8.0M FY25

We count pledges when the cash is received, not when they’re promised, so these numbers differ from HHT Foundation’s 990. How we count pledges

Where revenue came from, FY2025

Government grants
$4.4M · 55%
Gifts and grants
$2.9M · 36%
Program revenue
$471K · 6%
Noncash gifts
$207K · 3%
Fundraising events
$30K · 0%
Other revenue
− $10K
Total revenue on the 990
$9,841,516
Investment income
− $134,970
Pledges promised this year, not yet received
− $1,698,988
Revenue we count
$8,007,558

What it does

Hht foundation international, inc. Is a not-for-profit organization dedicated to serving individuals affected by hereditary hemorrhagic telangiectasia (hht). The organization provides information to patients, family members, and healthcare professionals; offers support and community for patients and their families; raises funds to advance basic and clinical research; and sponsors research grants to promote scientific studies focused on hht.

Research - the research program supports funding for studies that advance understanding of the underlying mechanisms of hht, fosters the development of novel therapeutic approaches for treatment and disease management, and promotes translational research that leads to multi-center clinical trials. In addition, the hht international scientific conference is held biennially to facilitate collaboration and the exchange of scientific knowledge among researchers and clinicians.
Education - the goal of the education program is to advance awareness, accurate diagnosis, and best-practice treatment of hht by supporting patient education and outreach, sponsoring educational conferences and professional meetings, and strengthening a network of comprehensive hht clinical centers of excellence.
Public information - the goal of the public information program is to increase awareness of hereditary hemorrhagic telangiectasia (hht) among the general public, private sector, and governmental audiences through strategic engagement with the press and other media channels.

Leadership

Marianne ClancyExecutive Director
Stefanie-Nicole SchaeferChief Operating Officer
Melissa DickeyDirector, Nat'l HHT Coordinating Center

EIN 22-3115041 · Full filings on ProPublica

Want to share your story?

We’d love to hear your story of growth.

Share your story